Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Atopic eczema: How to tackle the most common atopic symptom

Atopic eczema: How to tackle the most common atopic symptom The disease management of atopic eczema includes topical and systemic treatments as well as the control of allergic and non‐allergic trigger factors. The basis for topical treatment is the regular use of emollients. In addition, anti‐inflammatory treatment with – preferably mild – topical steroids is the treatment of choice. At least‐one third of the children with atopic eczema during the first years suffer from clinically relevant food allergy requiring elimination diets for at least one or two years. The most common cause of superinfection is Staphylococcus aureus. Recent data suggests that it may induce purulent superinfection as well as enhance the inflammatory process by superantigen mediated T‐cell activation. Also, a number of alternative treatment strategies have been investigated during the last decade: the use of γ‐linoleic acid has been shown to be of limited benefit, while studies on interferon‐γ and on high‐dose intravenous γ‐globulin are still anecdotal. The long‐term effectiveness of disease management in atopic eczema depends largely on the understanding of the disease process as well as on the compliance of the parents. Thus, coping with the problem will be easier if the patient or the parents have been educated in understanding the pathogenesis, the role of trigger factors, the possibilities of prevention and the different treatment strategies. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Pediatric Allergy and Immunology Wiley

Atopic eczema: How to tackle the most common atopic symptom

Download PDF
5 pages

Loading next page...
 
/lp/wiley/atopic-eczema-how-to-tackle-the-most-common-atopic-symptom-UkGxs2mKc3

References (25)

Publisher
Wiley
Copyright
1999 Munksgaard
ISSN
0905-6157
eISSN
1399-3038
DOI
10.1111/j.1399-3038.1999.tb00423.x
Publisher site
See Article on Publisher Site

Abstract

The disease management of atopic eczema includes topical and systemic treatments as well as the control of allergic and non‐allergic trigger factors. The basis for topical treatment is the regular use of emollients. In addition, anti‐inflammatory treatment with – preferably mild – topical steroids is the treatment of choice. At least‐one third of the children with atopic eczema during the first years suffer from clinically relevant food allergy requiring elimination diets for at least one or two years. The most common cause of superinfection is Staphylococcus aureus. Recent data suggests that it may induce purulent superinfection as well as enhance the inflammatory process by superantigen mediated T‐cell activation. Also, a number of alternative treatment strategies have been investigated during the last decade: the use of γ‐linoleic acid has been shown to be of limited benefit, while studies on interferon‐γ and on high‐dose intravenous γ‐globulin are still anecdotal. The long‐term effectiveness of disease management in atopic eczema depends largely on the understanding of the disease process as well as on the compliance of the parents. Thus, coping with the problem will be easier if the patient or the parents have been educated in understanding the pathogenesis, the role of trigger factors, the possibilities of prevention and the different treatment strategies.

Journal

Pediatric Allergy and Immunology – Wiley

Published: Aug 1, 1999

There are no references for this article.